1. Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma

   • Tatsuo Kanda
   • Osamu Yokosuka
   • Mitsuhiko Moriyama

   Editorial 16 August 2019 Pages: 519 - 520

   

2. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges

   • Lifeng Wang
   • Fu-Sheng Wang

   Review Article 27 July 2019 Pages: 521 - 533

   

3. Reversal of NASH fibrosis with pharmacotherapy

   • Joseph J. Alukal
   • Paul J. Thuluvath

   Review Article 30 July 2019 Pages: 534 - 545

   

4. Radiomics in hepatocellular carcinoma: a quantitative review

   • Taiga Wakabayashi
   • Farid Ouhmich
   • Benoit Gallix

   Review Article 31 August 2019 Pages: 546 - 559

   

5. The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose–response meta-analysis

   • Yue Shen
   • Sheng-Di Wu
   • Wei Jiang

   Original Article 04 July 2019 Pages: 560 - 572

   

6. Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study

   • Di Wu
   • Peng Wang
   • Qin Ning

   Original Article 06 June 2019 Pages: 573 - 586

   

7. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

   • Chung-Feng Huang
   • Etsuko Iio
   • For the REAL-C Investigators

   Original Article 28 August 2019 Pages: 587 - 598

   

8. The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015

   • Eun Sun Jang
   • Moran Ki
   • The Korean hepatitis epidemiology study group

   Original Article 20 August 2019 Pages: 599 - 608

   

9. Association between neutrophil–lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma

   • Yifei Zhang
   • N. Patrik Brodin
   • Rafi Kabarriti

   Original Article 01 August 2019 Pages: 609 - 617

   

10. Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis

    • Yongcong Yan
    • Yingjuan Lu
    • Zhiyu Xiao

    Original Article Open access 18 July 2019 Pages: 618 - 630

    

11. An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence

    • Bao-Yong Zhou
    • Jun-Hua Gong
    • Rui Liao

    Original Article 24 July 2019 Pages: 631 - 640

    

12. Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis

    • Natasha Kamal
    • Christopher Koh
    • for the Drug-Induced Liver Injury Network

    Original Article 07 August 2019 Pages: 641 - 648